Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-31

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trigger finger is a mechanical problem characterized by pain and catching of digit in flexion.

Histological changes of A1 pulley and synovial proliferation have been identified as factors that prompt trigger finger The first-line treatment of trigger finger is conservative with splinting and corticosteroid injection.

If the first infiltration fails, either a second infiltration or surgical sectioning of the pulley is proposed.

Surgery can be performed by several techniques (open section, percutaneous section with palpatory guidance, or under ultrasound guidance).

Percutaneous A1 pulley release under ultrasound guidance consists of cutting the A1 pulley by a percutaneous insertion with small needle under local anaesthesia.

The hypothesis of the study is that percutaneous A1 pulley release under ultrasound guidance followed by a corticosteroid injection would be more effective than a second corticosteroid injection alone on complete resolution of the trigger finger symptoms

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultrasound Guided Corticosteroid Injection at A1 Pulley in Comparison to Percutaneous A1 Pulley Release as a Treatment for Idiopathic Trigger Finger

NCT05170152

US-guided Release of the A1 Pulley Responsible for Trigger Finger is Feasible With a 21-gauge Needle

COMPLETED NA

Ultrasound Guided A1 Pulley Release For The Treatment of Trigger Finger

NCT02830672

Surgical Release of Ai Pulley Trigger Finger

COMPLETED PHASE2/PHASE3

Trigger Finger Treatment

NCT03847935

Trigger Finger Trigger Digit Stenosing Tenosynovitis

COMPLETED

Study of Open and Percutaneous Release of Acquired Trigger Thumb

NCT03679793

Trigger Thumb

COMPLETED NA

Comparison Between 2 Treatment Modalities of Trigger Finger: Ultrasound-guided Percutaneous Release of A1 Pulley by a Needle Knife Versus Ultrasound-guided Corticosteroid Injection in the Treatment of Trigger Finger

NCT06785935

Trigger Finger

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trigger Finger

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

percutaneous A1 pulley release with corticosteroid injection

Group Type EXPERIMENTAL

Percutaneous A1 Pulley Release Under Ultrasound Guidance

Intervention Type PROCEDURE

the A1 pulley is cut off with Ultrasound guidance by a percutaneous insertion of the small needle under local anaesthesia.

Corticosteroid injection

Intervention Type DRUG

corticosteroid injection is performed

corticosteroid injection alone

Group Type ACTIVE_COMPARATOR

Corticosteroid injection

Intervention Type DRUG

corticosteroid injection is performed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous A1 Pulley Release Under Ultrasound Guidance

the A1 pulley is cut off with Ultrasound guidance by a percutaneous insertion of the small needle under local anaesthesia.

Intervention Type PROCEDURE

Corticosteroid injection

corticosteroid injection is performed

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient ≥ 18 years old,
* Presence of a trigger finger (thumb or long fingers) to be treated
* Quinnell score \>1
* Episode of trigger characterized on questioning or clinical examination
* Failure of a first corticosteroid infiltration \> 3 months before inclusion
* First infiltration within 15 months of inclusion
* Thickening A1 pulley on ultrasound ≥ 0.5 mm
* Patient who has the capacity to understand the protocol and has given consent to participate in the research,
* Patient with social security coverage

Exclusion Criteria

* Presence of several symptomatic fingers requiring treatment by ultrasound-guided section of the pulley
* Patient who are pregnant, breastfeeding, or who have the potential to become pregnant without effective contraception at the time of inclusion
* Known allergy to corticoid (Hydrocortancyl®) including its excipients ((benzyl alcohol, sodium carmellose, sodium chloride, polysorbate 80)
* Known allergies to lidocaine
* Ongoing anticoagulant treatments (AVK, New Oral Anti-Coagulants)
* Local or general infection, or suspicion of infection
* Live vaccines
* Evolving viruses (hepatitis, herpes, varicella, shingles)
* Severe or uncontrolled hypertension
* Unbalanced diabetes
* Underlying progressive cardiovascular disease
* Hemodialysis patients
* Prosthesis on the finger to be treated
* Echographic tendon fissure
* Inflammatory disease (rheumatoid arthritis, spondyloarthritis, connective tissue diseases, etc.) with tenosynovitis.
* History of surgery on the fingers
* Dupuytren's disease
* Patient participating in another interventional clinical research protocol involving a drug or medical device
* Patient under guardianship, curators or legal protection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No